Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Interleukin-1 receptor antagonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Arthritis, Rheumatoid 2 D001172 ClinicalTrials
Diabetes Mellitus 2 D003920 ClinicalTrials
Osteoarthritis 2 D010003 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109458